Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.
about
Alzheimer's disease as homeostatic responses to age-related myelin breakdownBrain-derived neurotrophic factor signaling rewrites the glucocorticoid transcriptome via glucocorticoid receptor phosphorylationUnified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapyChronic Stress and Glucocorticoids: From Neuronal Plasticity to NeurodegenerationAre Anxiety Disorders Associated with Accelerated Aging? A Focus on NeuroprogressionChronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnelSleep, circadian rhythms, and the pathogenesis of Alzheimer diseaseInflammatory process in Alzheimer's DiseaseThe emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's diseaseThe neuropathology of sportGlucocorticoid-dependent hippocampal transcriptome in male rats: pathway-specific alterations with agingInvolvement of 5-lipoxygenase in the corticosteroid-dependent amyloid beta formation: in vitro and in vivo evidenceDexras1 interacts with FE65 to regulate FE65-amyloid precursor protein-dependent transcriptionFormulation of a medical food cocktail for Alzheimer's disease: beneficial effects on cognition and neuropathology in a mouse model of the diseaseOral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.Posttraumatic stress disorder-like induction elevates β-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses.Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.The involvement of Cdk5 activator p35 in social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit in the transgenic mice.Central CRF system perturbation in an Alzheimer's disease knockin mouse model.Stress-induced glucocorticoid signaling remodels neurovascular coupling through impairment of cerebrovascular inwardly rectifying K+ channel functionCorticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease.Tau protein is essential for stress-induced brain pathologyLW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice.Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNIAdverse stress, hippocampal networks, and Alzheimer's disease.Environmental novelty exacerbates stress hormones and Aβ pathology in an Alzheimer's model.Central angiotensin II stimulation promotes β amyloid production in Sprague Dawley rats.3xTgAD mice exhibit altered behavior and elevated Aβ after chronic mild social stressTargeting psychologic stress signaling pathways in Alzheimer's disease.Effects of chronic stress on memory decline in cognitively normal and mildly impaired older adults.Pathways linking late-life depression to persistent cognitive impairment and dementia.Dexamethasone potentiated Aβ-induced learning and memory impairment in rats.Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of ADChronic glucocorticoid exposure activates BK-NLRP1 signal involving in hippocampal neuron damage.Effects of stress and stress hormones on amyloid-beta protein and plaque deposition.Stress-induced tau phosphorylation: functional neuroplasticity or neuronal vulnerability?Antiglucocorticoid therapy for older adults with anxiety and co-occurring cognitive dysfunction: results from a pilot study with mifepristone.Multi-parametric profiling network based on gene expression and phenotype data: a novel approach to developmental neurotoxicity testing.Thyroid hormones are associated with poorer cognition in mild cognitive impairment.Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.
P2860
Q22251261-FB34C6F8-248D-4F6E-AF6B-D1FC0EDCC200Q24311305-B2C03C07-35CF-446F-92AE-A9C6BA6B0856Q26382049-FEEC4056-D814-4588-9F1B-609B4E8264F0Q26748974-5A93A680-5104-4AAB-8380-D968059E98C6Q26765559-08A4F5C9-1511-4D8C-B8F1-8E316CD8DAE2Q27001265-D43EDCA6-CA50-4101-8108-D1F597841091Q27024779-0745ED29-AC4D-4ECE-8F82-765F3FB15155Q27500412-4ECAACDB-DC20-4CCF-84F4-B656EE76008FQ28085108-55758CE8-AFC4-469E-B17C-B9D1840AE53BQ28383563-AFF8C9B0-27B8-4D4C-AE90-A7B7E072F321Q28385751-93BA4532-DB86-464A-8B7D-9F10DEC88B8BQ28476697-4E8A5C7F-5DC3-4177-8B6F-C267A53748C4Q28566591-2FB4106A-0826-497E-AF9C-E626A3DF59B1Q28748304-0520B004-199D-4DE6-8734-F455A3AA2DFEQ30277388-475CD3C2-35B2-4EAF-BDF7-C586E72E2906Q30405044-EFBBF290-6070-4311-885A-267B362E441FQ30494084-74511B0B-B074-4A73-98BE-D647C0004F62Q30503385-207B2457-60C9-40A3-9928-8F589391D883Q30514236-398A8554-1D70-4DC7-9C6B-AC0FAFF98E50Q30578856-18F6C6FD-4DC5-474E-8EAE-192CA94A4C7EQ30754529-CD7F32E9-AB26-4992-9D36-F824CA88A492Q30780692-C0C935DC-2AAB-4984-9C4F-9426C1EF9E6FQ30831806-03A195BA-CCCE-4159-8646-20767886EC1BQ31110973-2A45A9FE-2876-4C93-9EC0-A408A71E3AB9Q33708011-C7F0133D-8A8C-4EEA-9EED-6FF500A0646DQ33765768-2D67A950-D447-41F2-821F-26E360EDF15CQ33813065-78FCF1A9-484B-4194-9BB9-62F825E3AA0EQ33818420-CA3F55D1-DEC1-4C92-B2EE-E7B6B443E4A5Q33820375-0610FAD1-0A68-45FD-A7FD-B6D20A51EA76Q33827921-19544A10-2DCB-4209-A1CB-F3FD45573925Q33857662-EFF9B8E4-9C98-4377-AB18-66A61EC2F0DEQ33887604-1C274630-E3BF-4C70-BD40-6004577D93FAQ33894308-7B4472C5-B9DB-48DD-AD01-18FB1C65E39EQ33922862-2520DEE8-45FA-4806-9AE9-7D3B48DE1390Q34001966-B79EA46A-7B58-4A55-93CD-E47E8DFCFD1AQ34003380-2EF64656-54BF-4DC5-A97D-82AC771BAA59Q34067068-A8C87784-13A2-4A8F-BC25-41D9376C3694Q34152533-8C335EDF-1FB6-4FE6-A0B5-7680A7A894FDQ34168826-5B582DDC-A7C1-46BC-9AFC-13EA831B37A2Q34189447-445A6621-9323-4649-AFF9-C4E0E6374AD7
P2860
Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Glucocorticoids increase amylo ...... model of Alzheimer's disease.
@en
type
label
Glucocorticoids increase amylo ...... model of Alzheimer's disease.
@en
prefLabel
Glucocorticoids increase amylo ...... model of Alzheimer's disease.
@en
P2093
P1476
Glucocorticoids increase amylo ...... e model of Alzheimer's disease
@en
P2093
Benno Roozendaal
Frank M LaFerla
James L McGaugh
Kim N Green
Lauren M Billings
P304
P356
10.1523/JNEUROSCI.2797-06.2006
P407
P577
2006-08-01T00:00:00Z